Status:

COMPLETED

Quantitative EEG Markers in Mild Cognitive Impairment in Epilepsy

Lead Sponsor:

Mansoura University Hospital

Conditions:

Epilepsy

Eligibility:

All Genders

Brief Summary

Epileptic patients are plighted with limited daily activities, social dysfunction, family conflicts and cognitive impairment. Most of the studies had showed that cognitive disorders were frequent in p...

Detailed Description

Cognitive consequences in epilepsy are often described in the following domains: verbal memory, language, executive functions, and attention. However, most of the studies focus on one or two domains i...

Eligibility Criteria

Inclusion

  • Patients with clinically confirmed epilepsy in adult patients.
  • Non-symptomatic epilepsy.
  • Normal CT or MRI brain, and
  • Education level of primary school at least to respond to the scales correctly were included.

Exclusion

  • Psycho-neurological illnesses,
  • History of alcoholism or drug abuse, or
  • Recently on medications that may affect cognitive functions (like antidepressants and antipsychotic drugs).

Key Trial Info

Start Date :

March 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 1 2020

Estimated Enrollment :

90 Patients enrolled

Trial Details

Trial ID

NCT04376671

Start Date

March 1 2019

End Date

March 1 2020

Last Update

May 6 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Mansoura University Hospital

Al Mansurah, Egypt